News
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a ...
Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening ...
The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.
Amorepacific revealed research findings confirming the skin-regenerative effects of polydeoxyribonucleotides (PDRNs) ...
Ayu Life Sciences, an India-based medical devices and cell therapy company, announced plans to establish a new AED33 million ($9 million) advanced manufacturing facility at Jebel Ali Free Zone (Jafza) ...
Essentially my nervous system was fried, which meant I could not be in the world in the same way. Loud noises, too many ...
Dr Annie Black, Lancome's international scientific director, talks to Lounge about how pollution is affecting Indian skin and ...
SentinelOne® , a global leader in AI-powered cybersecurity, today announced its Singularitytm Platform has been named both Best Endpoint Security Solution and Best Cloud Security Management Solution ...
Presentations at WHS and SAWC to highlight EscharEx's mechanism of action, preclinical advantages over SANTYL®, and new data in treating V ...
PDRNs have been garnering attention in recent years for its efficacy in enhancing skin regeneration and wound healing ... by Outer Biosciences Inc., a biotechnology company in Boston, MA, USA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results